The Pretty Equity 2026 Execution Series

Three decision briefs for investors and serious founders navigating beauty, risk, and scale

Subscribe Today

Subscribe to receive Part I of the full 2026 Execution Series

    We respect your privacy. Unsubscribe at any time.

    Melory Johnson

    25-Year Beauty Veteran, Advisor & Strategist

    What Is It?

    Most beauty content focuses on storytelling, growth hacks, or inspiration.
    Very little focuses on what actually breaks beauty businesses after the pitch deck, the raise, or the viral moment.

    The Pretty Equity 2026 Execution Series is a three-part set of decision briefs created for investors and serious founders who want to understand where execution, regulatory, and scale risk actually lives in beauty—and how to identify it early.

    Each brief is designed to support real decisions, not surface-level learning.

    This series examines:

    • Why promising beauty brands fail after funding
    • Where diligence and compliance often give false confidence
    • What breaks when demand outpaces infrastructure
    • How execution risk compounds quietly until it becomes expensive

    Subscribers receive each brief as it is released in 2026.

    This is not a course.
    It is not a founder playbook.
    It is an execution lens for people allocating capital, inventory, and reputational risk.

    What will you receive?

    • Part I — The Beauty Execution Reality Check
      The Beauty Execution Reality Check is a concise decision brief that helps investors and serious founders identify the most common execution, regulatory, and scale-readiness failures in beauty brands before those risks surface as missed launches, stalled growth, recalls, or enforcement actions.

    • Part II — The Beauty Due Diligence Gap
      Why most diligence misses real risk, and how better questions change outcomes (May 2026)

    • Part III — The Scale Stress Test
      What happens when growth outpaces systems, suppliers, and safeguards (September 2026)